Use of herbal medicinal products containing estragole - Scientific guideline
Table of contents
This document provides information on the natural occurence, toxicity and pharmacokinetics of estragole. It gives recommendation on the safety of herbal medicinal products containing this substance.
Keywords: Herbal medicinal products; HMPC; estragole; fennel; fennel oil; anise, anise oil
-
List item
Public statement on the use of herbal medicinal products containing estragole - Revision 1 (PDF/382.81 KB)
Draft: consultation closed
First published: 14/02/2020
Last updated: 09/06/2023
Consultation dates: 15/02/2020 to 15/05/2020
EMA/HMPC/137212/2005 Rev. 1 Corr. -
List item
Overview of comments received on the draft revised Public statement on the use of herbal medicinal products containing estragole (EMA/HMPC/137212/2005 Rev 1 – 2nd Draft) (PDF/298.65 KB)
First published: 01/03/2022
EMA/HMPC/482974/2020 -
List item
Overview of comments received on the draft revised Public statement on the use of herbal medicinal products containing estragole (EMA/HMPC/137212/2005 Rev 1) (PDF/470.27 KB)
First published: 14/02/2020
EMA/HMPC/278706/2015
-
List item
Public Statement on the use of herbal medicinal products containing estragole (PDF/190.75 KB)
Adopted
First published: 23/11/2005
Last updated: 23/11/2005
EMEA/HMPC/137212/2005 -
List item
Public statement on the use of herbal medicinal products containing estragole (PDF/521.67 KB)
Draft: consultation closed
First published: 22/12/2014
Last updated: 22/12/2014
Consultation dates: 22/12/2014 to 31/03/2015
EMA/HMPC/137212/2005 Rev. 1 -
List item
Overview of Comments received on Public Statement on the use of herbal medicinal products containing estragole and on Public Statement on the use of herbal medicinal products containing methyleugenol (PDF/27.18 KB)
First published: 23/11/2005
Last updated: 23/11/2005
EMEA/381090/2005